NEOADJUVANT ENDOCRINE THERAPY FOR PATIENTS WITH ESTROGEN-RECEPTOR-POSITIVE BREAST CANCER
More than 70 % of patients with breast cancer have estrogen-receptor-positive tumors (ER+) and are considered hormone- sensitive. That is why a vast majority of patients with early operable tumors receive adjuvant endocrine therapy. Patients with metastatic ER+ breast cancer also receive hormone t...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artikel |
| Taal: | Russisch |
| Gepubliceerd in: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2018-07-01
|
| Reeks: | Сибирский онкологический журнал |
| Onderwerpen: | |
| Online toegang: | https://www.siboncoj.ru/jour/article/view/758 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|